FertileStart
A calmer, clearer start to trying to conceive
Home / Blog / When To Seek Help
when to seek help

When Should You Stop “Just Tracking” and Ask for a Fertility Evaluation?

Use ASRM’s age-based evaluation timelines plus reasons to seek help sooner.

Updated September 24, 2026Primary-source groundedEducational, not individualized care
Quick answerAge-based timelines are useful defaults, not waiting requirements. ASRM recommends evaluation after 12 months of trying for women under 35, after 6 months at 35 or older, and more promptly over 40 or when a known fertility-related condition is present.
Use this as a question-builder, not a treatment plan. Do not stop prescription medication or begin high-dose supplements based on a consumer article.

The decision in one minute

The shortest useful answer is this: Age-based timelines are useful defaults, not waiting requirements. ASRM recommends evaluation after 12 months of trying for women under 35, after 6 months at 35 or older, and more promptly over 40 or when a known fertility-related condition is present.

Use ASRM’s age-based evaluation timelines plus reasons to seek help sooner. This page stays focused on when to seek help, so you can use the information to make one concrete next decision instead of collecting more disconnected facts.

What this changes in practice

This matters because aSRM recommends evaluation after 12 months of trying for women under 35 and after 6 months at 35 or older.

This matters because over age 40, more immediate evaluation may be warranted.

CheckWhy it belongs in your decision
Point 1ASRM recommends evaluation after 12 months of trying for women under 35 and after 6 months at 35 or older.
Point 2Over age 40, more immediate evaluation may be warranted.
Point 3Known conditions associated with infertility are reasons not to wait for the calendar threshold.
Point 4Evaluation should consider ovulation, uterine/tubal factors, and semen when applicable.
Point 5The point of tracking is to inform care, not to postpone it indefinitely.

Where people get tripped up

The evidence-guided takeaway is that Known conditions associated with infertility are reasons not to wait for the calendar threshold.

In practice, Evaluation should consider ovulation, uterine/tubal factors, and semen when applicable.

How to turn the information into a better decision

This matters because the point of tracking is to inform care, not to postpone it indefinitely.

This is where people often turn a useful clue into an unsupported conclusion. The safest interpretation is the one that answers the question the test, tracker, symptom, or product was actually designed to answer—and stops there.

Put this inside the larger fertility picture

Age, cycle pattern, time trying, prior pregnancy history, uterine/tubal factors, and semen factors can all change how the same consumer result or lab value is interpreted.

ACOG recommends reviewing medications, supplements, chronic conditions, immunizations, nutrition, genetic history, and STI screening as appropriate before pregnancy. That broad preconception work is often more valuable than optimizing one isolated metric.

ASRM recommends evaluation after 12 months of trying for women under 35, after 6 months at 35 or older, and more promptly over 40 or when a known fertility-related condition is present.

What to bring to a clinician or product decision

Bring the actual data, not just the conclusion an app gave you: cycle dates, screenshots or logs if relevant, laboratory units and reference ranges, medication and supplement labels, and the dates of prior tests.

Ask what the result predicts well, what it does not predict, and what decision changes because of it. If nobody can name the decision, more testing may not be buying you much.

When a product is involved, compare total daily cost, adherence burden, ingredient or measurement transparency, and whether the feature solves a problem you actually have.

Save-this checklist

  • ASRM recommends evaluation after 12 months of trying for women under 35 and after 6 months at 35 or older.
  • Over age 40, more immediate evaluation may be warranted.
  • Known conditions associated with infertility are reasons not to wait for the calendar threshold.
  • Evaluation should consider ovulation, uterine/tubal factors, and semen when applicable.
  • The point of tracking is to inform care, not to postpone it indefinitely.
Useful habit: save the exact test name, specimen site, laboratory value, product label, or tracking date that created the question. Screenshots beat memory.

Decision-note builder

Use this to turn the topic into a short note you can save before a clinician visit or shopping decision.

Frequently asked questions

Can when should you stop “just tracking” and ask for a fertility evaluation? tell me whether I will get pregnant?

No single test, tracker, supplement, or diagnosis can answer that on its own. Fertility depends on multiple factors, and the same finding can have different implications depending on age and the rest of the evaluation.

When should I ask for a fertility evaluation?

ASRM recommends evaluation after 12 months of trying for women under 35, after 6 months at 35 or older, and more promptly over 40 or when a known fertility-related condition is present.

Should my partner be evaluated too?

When applicable, yes. ASRM recommends parallel evaluation of the male partner, including semen evaluation, rather than assuming the issue is only on one side.

Should I change medication or supplements based on this page?

No. Use the page to prepare questions. ACOG recommends reviewing prescription drugs, over-the-counter products, supplements, and herbal products during preconception care.

Related reading

Primary guidance used

  1. ACOG: Prepregnancy Counseling
  2. ASRM: Fertility Evaluation of Infertile Women

Guidance and product authorizations change. When timing or treatment matters, use the current linked guidance or a clinician rather than relying on a cached summary.

Affiliate disclosure: Some pages on this site may contain affiliate links. Editorial conclusions should not depend on whether a product or service pays a commission.